effect of clonidine in rhinoplasty
Phase 3
- Conditions
- pain.Pain, not elsewhere classified
- Registration Number
- IRCT20180601039936N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
rhinoplasty candidate people without systemic disease
people with twenty aged and above
people without systemic disease
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: first 24 hours. Method of measurement: The pain status of patients is measured using the Visual Analog Scale (VAS), and patients are asked to specify a range of 0 to 10 for their pain levels.;Blood pressure. Timepoint: in first 24 hours. Method of measurement: blood pressure recorded in intervals.;Ecchymosis amount. Timepoint: ecchymosis was recorded in first third and seventh day after operation. Method of measurement: ecchymosis in every anatomical area has one point and grading was from zero to thirteen.;Analgesic amount request. Timepoint: in first 24 hours. Method of measurement: analgesic request from patients that was paracetamol (acetaminophen) was recorded.;Analgesic time. Timepoint: in first 24 hours. Method of measurement: analgesic period that equal to no analgesic request was recorded.
- Secondary Outcome Measures
Name Time Method Ecchymosis amount. Timepoint: Ecchymosis was recorded in first third and seventh day after operation. Method of measurement: Ecchymosis in every anatomical area has one point and grading was from zero to thirteen.